Clinical Trials Logo

Filter by:
NCT ID: NCT02197416 Completed - Clinical trials for Venous Thromboembolism

Safety of Dabigatran Etexilate in Blood Clot Prevention in Children

Start date: September 29, 2014
Phase: Phase 3
Study type: Interventional

This open-label, single arm prospective cohort study will assess the safety of dabigatran etexilate in secondary prevention of venous thromboembolism in paediatric patients. Children from 0 to less than 18 years of age will be eligible to participate.

NCT ID: NCT02197000 Completed - BRCA2 Gene Mutation Clinical Trials

A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers

Start date: November 11, 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether adding DIM supplement will decrease breast density among female BRCA mutation carriers in two years.

NCT ID: NCT02196987 Recruiting - Pain Clinical Trials

Does the Act of Urination During Urethral Catheterisation in Males Reduce Pain?

Start date: July 2014
Phase: N/A
Study type: Observational

Currently, there are no specific guidelines or best practice suggestions for best male catheterization as fat as insertion technique. There is however, information as to reducing infection, and as to recommended lubricant. From our experience, the investigators have noticed that when requesting the patient to attempt urination while inserting a urethral catheter, the level of pain and discomfort is reduced. In this study, the investigators will evaluate the pain level during male urethral catheterization in each technique. Our hypothesis is that the level of pain will be much less if the in the study group where the act of urination will be requested from the patient.

NCT ID: NCT02195076 Recruiting - Breast Cancer Clinical Trials

Non Invasive Detection of Lung and Breast Cancer by Odor Signature

Start date: July 2014
Phase: N/A
Study type: Observational [Patient Registry]

The investigators have developed an early detection solution for lung and breast cancer. A system which can distinguish between different medical odors based on biosensors. Our product is user-friendly noninvasive, nonradioactive and nontoxic to the patients. The technology enables a high level of sensitivity and provides users with a quick lab response and a simple yes or no answer. The aim of this study is to contribute and detect the patient at the earliest possible stage, in a noninvasive, nonradioactive and nontoxic way. Exhaled breath and urine samples are a promising approach towards future possible lung and breast cancer screening method.

NCT ID: NCT02194140 Not yet recruiting - Appendicitis Clinical Trials

Improvement of Appendix Identification and Appendicitis Diagnosis in us After Administration of Oral Contrast Medium

us
Start date: July 2014
Phase: N/A
Study type: Interventional

Rate of appendix localization on ultrasound is not high. We suggest a way to improve it's localization by oral administration of iodinated contrast material.

NCT ID: NCT02193581 Completed - Skin Lesion Clinical Trials

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

Start date: August 30, 2017
Phase: N/A
Study type: Observational

The use of MDS to access the presence of melanoma in the skin.

NCT ID: NCT02193516 Not yet recruiting - Nephropathy Clinical Trials

Identification of Corticomedullary Differentiation Along Different Stage of Pregnancy

Start date: July 2014
Phase: N/A
Study type: Observational

Corticomedullary differentiation (CMD) abnormality (absent/reversed) is a parameter that can indicate possible nephropathy. The evolution of CMD across gestation had not been well established. Devrendt et al demonstrated the presence of CMD in all fetuses older then 20 weeks. In our study we would like to determine the exact timing of it's sonographic visualisation. This is a prospective study recruiting women between 14-24 week gestation during routine ultrasound screening. A midsagittal image of each kidney will be taken by a single sonographer and examined for the presence of the CMD by two other sonographers blinded to gestational age.

NCT ID: NCT02192801 Not yet recruiting - Proteinuria Clinical Trials

Kidney Function in Patients With Bladder Exstrophy

Start date: April 2014
Phase: N/A
Study type: Observational

Patients with classical bladder exstrophy undergo many surgical interventions with secondary urinary tract infections complicating their course. lately primary definitive surgical correction of this congenital anomaly has been implemented with satisfactory results. Although bladder exstrophy patients are born with normal kidneys, infectious and mechanical surgical complications can potentially damage their kidneys in the long-term. therefore we decided to evaluate renal function in the long-term in these patients.

NCT ID: NCT02191722 Completed - Clinical trials for Juvenile Idiopathic Arthritis

"Medikidz Explain JIA Comic Book- Hebrew"

Start date: August 2014
Phase: N/A
Study type: Interventional

We believe, that the results of this study will show that children learn from the comic book about their disease, and are now more aware and less frightened about it, and increase their compliance.

NCT ID: NCT02191423 Not yet recruiting - Clinical trials for Postpartum Depression

Oxytocin and Dyadic Psychotherapy in the Treatment of Post Partum Depression

Start date: January 2015
Phase: N/A
Study type: Interventional

Rationale and Hypotheses of the Current Research: the investigators speculate that mothers suffering from PPD exhibit high levels of depression and low levels of OXT, hence experiencing the interaction with their child as less rewarding, which in turn promote further depressive symptoms and interfere with child development. While dyadic psychotherapy has been studied in this context, it is unknown which depressed women will respond to this type of therapy, and whether such a response is mediated by the pro-bonding effect of oxytocin. The aim of this study is three-fold: 1. To study the effect of the administration of a single dose (24IU) of oxytocin on cerebral circuit processing and connectivity of empathy and attachment. 2. To examine whether the clinical response of mothers suffering from postpartum depression to short term dyadic psychotherapy (based on improved mother-child interactions) can be predicted by a unique brain response pattern to oxytocin. 3. To assess the relationship between levels of oxytocin in mother and baby and the effectiveness of psychological dyadic treatment on mothers suffering from postpartum depression.